Second Federal Vioxx MDL Trial Postponed to July 31




NEW ORLEANS - Attorneys have announced that the second federal Vioxx MDL trial scheduled against Merck & Co. Inc. will be delayed one week and is now scheduled to begin July 31 because of a recent health problem experienced by the plaintiff. In Re: Vioxx Products Liability, MDL No. 1657 (E.D. La.).

The Plaintiffs' Steering Committee said on July 13 that plaintiff Gerald D. Barnett, 62, had recently been suffering from chest pain and required a stent to prop open one of his arteries.

In the case at issue, Barnett v. Merck & Co. Inc., No. 06-485, Barnett, a retired …






UPCOMING CONFERENCES




HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 25, 2025 - Buffalo, NY
The Westin Buffalo

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS